HCIA
CELG

Hochman Cole Investment Advisors’s Celgene Corp CELG Stock Holding History

Hochman Cole Investment Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,685
Closed -$236K – 113
2018
Q4 		$236K Sell
3,685
-2,431
-40% -$179K 0.16% 98
2018
Q3 		$547K Sell
6,116
-145
-2% -$12.8K 0.34% 54
2018
Q2 		$497K Buy
6,261
+1,744
+39% +$145K 0.33% 57
2018
Q1 		$403K Buy
4,517
+1,905
+73% +$183K 0.28% 59
2017
Q4 		$273K Buy
+2,612
New +$295K 0.17% 82

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hochman Cole Investment Advisors's CELG Position: Q1 2019 in Review

Hochman Cole Investment Advisors sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 3,685 shares — an estimated $236K sold.

Hochman Cole Investment Advisors first reported a position in CELG in Q4 2017 and held it in 5 quarters. The position peaked at $547K in Q3 2018. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Hochman Cole Investment Advisors reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Hochman Cole Investment Advisors sold 3,685 Celgene Corp shares in Q1 2019, an estimated $236K.
  • Hochman Cole Investment Advisors first reported a position in Celgene Corp in Q4 2017 and held it in 5 quarters.
  • Hochman Cole Investment Advisors's Celgene Corp position peaked at $547K in Q3 2018.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Hochman Cole Investment Advisors's 13F filing for Q1 2019, filed 26 Apr 2019.